Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Rhinitease** is a non-specific Shayana Farm nasal-product family rather than one chemically defined drug. The family includes **Rhinitease-P/Rinitiz-P**, a metered intranasal spray containing fluticasone propionate for prevention and treatment of seasonal allergic rhinitis and persistent rhinitis, and **Rhinitease XI/Rinitiz XI**, a metered intranasal xylometazoline product with dexpanthenol-containing excipients used as a topical nasal decongestant for rhinitis-related congestion, sinusitis, and related ENT indications. Because these variants contain different active substances and have different mechanisms, no single molecular target or mechanism can be assigned to Rhinitease without the product suffix. ([shayanafarm.com](https://shayanafarm.com/productions/rhinitease-p-2/))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rhinitease.